Adjuvant docetaxel for high-risk, node-negative breast cancer.

Saved in:
Bibliographic Details
Title: Adjuvant docetaxel for high-risk, node-negative breast cancer.
Authors: Martín M; Hospital General Universitario Gregorio Marañón, Madrid, Spain. mmartin@geicam.org, Seguí MA, Antón A, Ruiz A, Ramos M, Adrover E, Aranda I, Rodríguez-Lescure A, Grosse R, Calvo L, Barnadas A, Isla D, Martinez del Prado P, Ruiz Borrego M, Zaluski J, Arcusa A, Muñoz M, López Vega JM, Mel JR, Munarriz B, Llorca C, Jara C, Alba E, Florián J, Li J, López García-Asenjo JA, Sáez A, Rios MJ, Almenar S, Peiró G, Lluch A
Corporate Authors: GEICAM 9805 Investigators
Source: The New England journal of medicine [N Engl J Med] 2010 Dec 02; Vol. 363 (23), pp. 2200-10.
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1533-4406
DOI:10.1056/NEJMoa0910320